本页面由Tiger Trade Technology Pte. Ltd.提供服务

Finch Therapeutics Group, Inc.

13.25
-0.1125-0.84%
成交量:3,257.00
成交额:4.36万
市值:2,127.64万
市盈率:-1.50
高:13.25
开:13.20
低:13.20
收:13.36
52周最高:16.10
52周最低:11.50
股本:160.58万
流通股本:111.54万
量比:3.46
换手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-8.8239
每股收益(LYR):-46.5888
净资产收益率:-67.28%
总资产收益率:-21.89%
市净率:1.50
市盈率(LYR):-0.28

数据加载中...

2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/31

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/10/21

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

重要事件披露

Form 8-K - Current report
2023/12/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]